Translation and Clinical Implementation of a Test of Language and Short-term Memory in Aphasia. (Clinical TALSA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03635554|
Recruitment Status : Recruiting
First Posted : August 17, 2018
Last Update Posted : August 20, 2018
|Condition or disease|
Over five years, we will develop a clinically feasible test that can be used to assess in-depth the language and verbal short-term memory abilities of individuals with aphasia (Called the TALSA - Temple Assessment of Language and Short-term memory in Aphasia. Based on a test that we have developed and tested over the past decade, we will create a shorter version that can be used by clinicians in a rehabilitation setting. The data to support this development will come from two sources: (1) clinicians in rehabilitation facilities who will use the new clinical test and provide feedback on the test (administration, value etc) and (2) people with aphasia who will be administered the longer version to help us identify the best test items in the laboratory version of the TALSA to be carried over to the shorter clinical version.
We are recruiting individuals with aphasia as well as people without aphasia (to serve as controls) to help with development of this assessment battery. The battery consists of between 15 and 20 subtests that assess many aspects of language and verbal short-term memory.
|Study Type :||Observational|
|Estimated Enrollment :||150 participants|
|Official Title:||Translation and Clinical Implementation of a Test for Language and Short-term Memory in Aphasia.|
|Actual Study Start Date :||December 15, 2017|
|Estimated Primary Completion Date :||November 30, 2022|
|Estimated Study Completion Date :||November 30, 2022|
- Proportions correct on subtests of the Test of Language and Short-term Memory in Aphasia (TALSA) [ Time Frame: two to three years December 1, 2017 through December 15, 2017 through November 30, 2022. ]Participants will be administered 15-20 subtests of the TALSA that assess aspects of language (phoneme discrimination, sentence comprehension) and short-term memory (e.g., repetition span) abilities. Their responses on these measures will be evaluated in a item response analysis to determine which items are ideal to use in a smaller version of this test that is feasible to use in clinical practice. Another group of people with aphasia will be administered the clinical version (when it is complete) to develop normative data for that assessment battery.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03635554
|Contact: Nadine Martin, Ph.D.||215 294 email@example.com|
|Contact: Wendy Greenspan, MAfirstname.lastname@example.org|
|United States, Pennsylvania|
|Philadelphia, Pennsylvania, United States, 19122|
|Contact: Nadine Martin, Ph.D. 215-204-1870 email@example.com|
|Contact: Wendy Greenspan, MA 215 204 1790 firstname.lastname@example.org|
|United States, Washington|
|University of Washington||Recruiting|
|Seattle, Washington, United States, 98105|
|Contact: Diane Kendall, Ph.D. 206-616-0537 email@example.com|
|Contact: JoAnn Silkes, Ph.D. 1 206 543-9005 firstname.lastname@example.org|
|Principal Investigator:||Nadine Martin, Ph.D.||Temple University|